Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Coral Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 557 users | BSE: 524506 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 12.96%15.32%14.15%16.69%16.41%18.18%18.28%10.29%7.89%5.12%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 32.74041.550.859.47795.592.591.170.698
Y-o-Y Gr. Rt.-22.2%3.9%22.4%17%29.6%24%-3.1%-1.5%-22.5%-
Adjusted EPS (Rs.) 11.615.0716.0521.9625.2432.8646.1632.6425.4416.639.44
Y-o-Y Gr. Rt.-29.9%6.5%36.8%14.9%30.2%40.5%-29.3%-22.1%-34.8%-
Book Value per Share (Rs.) 92.69106.76121.89141.57165.35196.44305.54325.63318.45323.77398.73
Adjusted Net Profit 4.15.45.77.9911.716.511.79.15.914
Net Op. Cash Flow (Rs. Cr.) 3.230.110.45.110.813.5-0.9-3.9-
Debt to Cash Flow from Ops 0.0505.270.193.680.070.20.13-1.63-1.53-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Coral Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 8.9%3.5%-9.6%-22.5%
Adjusted EPS 4.1%-8%-28.9%-34.8%
Book Value per Share 14.914.421.7
Share Price 17.2% -8.9% -1.1% 4.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 13.2215.1114.0416.6716.4518.1618.3910.347.95.1710.92
Operating Profit Margin (%) 18.5218.9718.1919.8720.7521.424.4316.5913.647.6817.19
Net Profit Margin (%) 12.6713.4713.8115.4415.1815.2417.2712.619.988.414.36
Debt to Equity 000.0100.020.010.020.010.010.05-
Working Capital Days 185174229224235241229243247332-
Cash Conversion Cycle 86727992130127127140129181-
Loading price chart...
Entity Percentage Holding
Promoters 71.51%
Institutions 0.42%
Non-Institutions 28.07%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Coral Laboratories Ltd's earnings have declined by -8%, whereas share price has declined -8.9% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Coral Laboratories Ltd share price has appreciated 17.2% annually (CAGR) over the past ten years.

Data is not available for this company.

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of “Total Quality Management” & “Quality Products at Affordable Prices”.

The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK – MHRA and US– FDA certification.

Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.

Product range of the company includes:

  • Capsules & Dry Syrups
  • Tablets
  • Liquid Orals
  • Kits
  • Ointment & Cream
  • Injection – Eye – Ear Drops
  • Others

Achievements/ recognition:

  • WHO GMP certification issued by the Food & Drugs Control Administration
  • ISO 9001-2000 Quality certification issued by American Quality Assessors.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback